Nuvalent (NUVL) Accumulated Expenses (2020 - 2026)

Nuvalent (NUVL) reported Accumulated Expenses of $58.9 million for Q1 2026, up 20.56% on a YoY basis from $48.9 million in Q1 2025, and up 247.89% quarter-over-quarter from $16.9 million in Q4 2025.

Nuvalent (NUVL) Accumulated Expenses (2020 - 2026) Analysis & Trends

Nuvalent has reported Accumulated Expenses for 7 years, with the latest figure at $58.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Accumulated Expenses rose 20.56% year-over-year to $58.9 million; the trailing twelve-month figure through Mar 2026 stood at $58.9 million (up 20.56% YoY), and the FY2025 full-year result was $16.9 million, up 62.03% from the prior year.
  • Accumulated Expenses for Q1 2026 stood at $58.9 million, up from $16.9 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $67.1 million in Q3 2025, with the low at $3.9 million in Q1 2022.
  • Historically, Accumulated Expenses has averaged $23.0 million across 5 years, with a median of $16.9 million in 2025.
  • Annual changes were most pronounced in 2022 — Accumulated Expenses soared 195.81% — and 2025, when it plunged 74.69%.
  • Nuvalent's Accumulated Expenses stood at $12.3 million in 2022, then soared by 83.53% to $22.5 million in 2023, then tumbled by 53.65% to $10.5 million in 2024, then soared by 62.03% to $16.9 million in 2025, then surged by 247.89% to $58.9 million in 2026.
  • The last three Accumulated Expenses figures came in at $58.9 million (Q1 2026), $16.9 million (Q4 2025), and $67.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Nuvalent 9.70 Bn 9.70 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 58.92 Mn
Dec 31, 2025 16.94 Mn
Sep 30, 2025 67.14 Mn
Jun 30, 2025 7.79 Mn
Mar 31, 2025 48.87 Mn
Dec 31, 2024 10.45 Mn
Sep 30, 2024 35.20 Mn
Jun 30, 2024 30.79 Mn
Mar 31, 2024 20.03 Mn
Dec 31, 2023 22.55 Mn
Sep 30, 2023 19.32 Mn
Jun 30, 2023 12.68 Mn
Mar 31, 2023 10.59 Mn
Dec 31, 2022 12.29 Mn
Sep 30, 2022 8.36 Mn
Jun 30, 2022 6.01 Mn
Mar 31, 2022 3.88 Mn
Dec 31, 2021 5.89 Mn
Sep 30, 2021 4.31 Mn
Jun 30, 2021 2.03 Mn